CAS No |
Product Name |
Molecular Formula |
2380027-49-4
|
Src Inhibitor 3
|
C34H32ClFN8O4
|
2380230-73-7
|
2-[2-[[3-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]phenyl]carbonylamino]phenyl]ethanoic acid
|
C27H29N3O3
|
2381089-83-2
|
Retatrutide
|
C227H354N48O69
|
2381400-91-3
|
2-Methyl-2-propanyl (4S)-4-amino-3,3-difluoro-1-pyrrolidinecarboxylate
|
C9H16F2N2O2
|
2381627-87-6
|
Carfilzomib Impurity 59
|
C14H25NO4
|
2381854-90-4
|
Fmoc-N-Me-3-(4-py)-L-Ala
|
C24H22N2O4
|
2382442-97-7
|
Oseltamivir Impurity 207
|
C12H18O4
|
2382664-60-8
|
4-Chloro-2-(morpholinomethyl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde
|
C19H18ClN3O4S
|
2384108-14-7
|
Cefazolin EP Impurity B
|
C16H20N4O4S3
|
2385124-34-3
|
3-bromo-5-fluoro-N-methylpyridin-2-amine
|
C6H6BrFN2
|
2387020-93-9
|
Terbutaline Impurity 30
|
C8H7BrO3
|
2387538-18-1
|
2-Chloro-4-neopentylpyridine
|
C10H14ClN
|
2387728-91-6
|
1-[4-Ethoxy-3-(hydroxymethyl)phenyl]-2-[(2-methyl-2-propanyl)amino]ethanol
|
C15H25NO3
|
2389125-23-7
|
Y6-BO-4F
|
C88H98F4N8O2S5
|
2389125-24-8
|
BTP48C11-2CHO
|
C66H98N4O2S5
|
2392930-05-9
|
2-Chloro-4,6-di(dibenzofuran-1-yl)-1,3,5-triazine
|
C27H14ClN3O2
|
2395025-37-1
|
Cefoxitin EP Impurity F
|
C17H19N3O8S2
|
2396570-49-1
|
2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine
|
C30H21N9
|
2397634-28-3
|
1-N,1-N,3-N,3-N,5-N-pentakis-phenylbenzene-1,3,5-triamine
|
C36H29N3
|
2402776-83-2
|
Baricitinib Impurity 24
|
C16H17N7O2S
|
2402776-84-3
|
Baricitinib Impurity 16
|
C23H27N9O4S2
|
2407527-16-4
|
Enlicitide chloride
|
C82H110ClFN14O15
|
2407529-33-1
|
(1R,3R)-1-[2,6-Difluoro-4-[[1-(3-fluoropropyl)-3-azetidinyl]amino]phenyl]-$greek946$,$greek946$-difluoro-1,3,4,9-tetrahydro-3-methyl-2H-pyrido[3,4-b]indole-2-propanol (2R,3R)-2,3-dihydroxybutanedioate (1:1)
|
C27H31F5N4O .C4H6O6
|
2408008-09-1
|
9-Phenyl-N-(2-phenylphenyl)carbazol-2-amine
|
C30H22N2
|
2408053-56-3
|
Sacubitril Methyl Ester
|
C23H27NO5
|
2408294-08-4
|
Methanesulfonato 1,1'-Bis(di-tert-butylphosphino) ferrocene (2'-amino-1,1'-biphenyl-2-yl) palladium(II)
|
C39H49FeNO3P2PdS
|
2408495-96-3
|
Budesonide 21-Butyrate Impurity
|
C29H40O7
|
2408495-97-4
|
Budesonide Impurity 30
|
C29H38O7
|
2408705-92-8
|
2,4-Dichloro-6-(dibenzo[b,d]furan-1-yl)-1,3,5-triazine
|
C15H7Cl2N3O
|
2408968-92-1
|
(1-(Aminomethyl)-2-oxabicyclo[3.1.1]heptan-5-yl)methanol hydrochloride
|
C8H16ClNO2
|
2409005-96-3
|
3-(5-Bromo-6-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
|
C13H10BrFN2O3
|
2409132-63-2
|
Elagolix Formamide
|
C29H24F5N3O4
|
2409479-29-2
|
(R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one
|
C27H30F3N9O
|
2409562-95-2
|
1-Bromo-5-(tert-butyl)-2,3-dichlorobenzene
|
C10H11BrCl2
|
2410075-48-6
|
7-Ketoabiraterone acetate
|
C26H31NO3
|
2410195-20-7
|
Imatinib Impurity K
|
C17H15N5O
|
2410195-23-0
|
Imatinib Dipiperazine Impurity
|
C41H45N9O2
|
2410284-89-6
|
Nintedanib Impurity 22
|
C22H30N6O2
|
2410284-90-9
|
Nintedanib Impurity 33
|
C56H52N8O8
|
2410401-58-8
|
N-(Dibenzo[b,d]furan-3-yl)-9-phenyl-9H-carbazol-2-amine
|
C30H20N2O
|
2410649-54-4
|
Nintedanib Impurity 28
|
C22H26N6O6
|
2412168-64-8
|
2-(2,5-Difluorophenyl)-4,6-diphenyl-1,3,5-triazine
|
C21H13F2N3
|
2412952-92-0
|
Sugammadex Impurity 9 Octasodium salt
|
C72H104O48S9 .8Na
|
2412952-93-1
|
Sugammadex Thiolactic Acid Impurity 1 Octasodium Salt
|
C72H104Na8O48S8
|
2412952-94-2
|
Sugammadex Thiolactic Acid Impurity 2 Octasodium Salt
|
C72H104O48S8 .8Na
|
2412952-95-3
|
Sugammadex Impurity 06
|
C71H102O48S8 .8Na
|
2412952-96-4
|
Dimethyl Amino Sugammadex
|
C71H106NNa7O46S7
|
2412953-06-9
|
Sugammadex Sodium Impurity 12
|
C138H200O92S15 .14Na
|
2412953-09-2
|
Sugammadex Sodium Impurity 11
|
C72H104O50S8 .8Na
|
2412953-13-8
|
Sugammadex Diastereomer 1 Sulfoxide (Sodium salt)
|
C72H112O49S8 .8Na
|